Regulatory

  1. Increase The Titer Of A Difficult To Express Molecule 12/11/2019

    What happens if you have a promising molecule but can’t engineer a cell line to deliver the titer needed to support clinical development?  A low process titer may render the molecule, such as an antibody, too costly to manufacture and unsuitable for continued investment. Learn how our client achieved a nearly 4-fold titer increase.

  2. Making Data Work 12/16/2019

    What is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.

  3. Do Novel Workflows Increase Regulatory Scrutiny? 5/16/2025

    David Bruehlmann, Ph.D. addresses continuous manufacturing in biopharma from the regulator’s perspective before sharing his view of where the technology is going next in this segment of the Bioprocess Online Live event Process Optimization or Full-Scale Automation. We discuss the chasm between the positive perception of continuous versus actual adoption, and discuss upcoming Bioprocess Online Live event programming.

  4. Effective Processes For Virus Purification 6/25/2018

    An informative presentation focused on understanding the challenges in virus/VLP purification, choosing the appropriate (or right) chromatography media for the production virus particles, and developing chromatography methods for optimal binding selectivity and recovery of virus particles.

  5. Biosimilars Are Booming: The Current Landscape 4/25/2025

    Celltrion VP of Medical Affairs Hetal Patel, PharmD, MBA and Biosimilars Forum Executive Director Juliana Reed kicked off our Bioprocess Online Live panel discussion Impact Of The Biosimilars Boom with an up-to-the-minute review of the biosimilars landscape, including key regulatory aspects, manufacturing complexity, and interchangeability.

  6. Introducing The Thermo Scientific™ DynaDrive Single-Use Bioreactor 11/26/2019

    Explore a single-use bioreactor that has been fully optimized for modern cell culture processes with a cubical vessel design and an innovative, efficient mixing system.

  7. Meet The Experts: Part 3 - Chemometrics And Model Building 5/1/2023

    Watch part 3 of this 4-part interview series to learn about chemometrics and model building from expert Johan Cailletaud.

  8. Single-Use Filter Transfer Sets Ready For Final Filling 9/6/2022

    Our industry-first, preconfigured filter transfer set for final filling arrives up to 80% faster, is PUPSIT-optimized, sterile and ready to use.

  9. How To Best Optimize mRNA Production Workflows 4/11/2023

    Multiple steps in the mRNA manufacturing process can appear more complex than they have to be. Learn how to simplify your approach and produce the best possible mRNA vaccines and therapeutics.

  10. Steering Through Setbacks with AVEO Oncology's Michael Bailey 8/18/2024

    For all the drug commercialization successes he's played a leading hand in during his tenures at GSK, Genentech, and ImClone — Androderm, Augmentin, necitumumab, and Erbitux among them — Michael Bailey concedes that he's likely better known for his failures. After hearing his stories on this episode of the Business of Biotech, I tend to disagree.